Corvita Corporation
This article was originally published in The Gray Sheet
Executive Summary
Receives $2 mil. from the second closing of "an $11.9 mil. mezzanine financing"; the lead investor was Trinity Ventures Limited. The firm received $9.9 mil. from the first closing on Nov. 5, 1992 ("The Gray Sheet" Nov. 23, p. 18). The privately held, Miami, Florida-based company is conducting clinical trials for a line of small- and medium-diameter vascular grafts manufactured from spun polycarbonate urethane fibers. The company expects to begin commercial sales of the grafts in the Benelux countries and in France in April.